Literature DB >> 6548080

Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases.

E A Ryan, E Reiss.   

Abstract

The clinical and biochemical data in 42 reported cases of oncogenous osteomalacia are reviewed, and data in two previously unreported cases are recorded. It is likely that the syndrome is more common than suggested by the paucity of reports and may account for a substantial fraction of nonfamilial, adult-onset "idiopathic" osteomalacia. Tumors associated with the syndrome are characteristically benign, of mesenchymal origin, highly vascular, and composed principally of giant and spindle cells. Complete excision of tumors results in cure of the osteomalacia in the majority of patients. The syndrome presumably represents an instance of humor-induced phosphaturia but supporting experimental data are scanty. Plasma levels of 1,25-dihydroxycholecalciferol are uniformly low, and treatment with this metabolite is generally very effective; however, abnormal vitamin D metabolism cannot by itself account for the syndrome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6548080     DOI: 10.1016/0002-9343(84)90112-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  27 in total

Review 1.  Recent advances in renal phosphate handling.

Authors:  Emily G Farrow; Kenneth E White
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

Review 2.  [Tumor-induced osteomalacia caused by an FGF23-secreting myopericytoma : Case report and literature review].

Authors:  N Muro Bushart; L Tharun; R Oheim; A Paech; J Kiene
Journal:  Orthopade       Date:  2020-01       Impact factor: 1.087

3.  Phosphaturic mesenchymal tumor with chondromyxoid fibroma-like feature: an unusual morphological appearance.

Authors:  Pallavi Suryawanshi; Manish Agarwal; Rahul Dhake; Saral Desai; Bharat Rekhi; Kishor B Reddy; Nirmala Ajit Jambhekar
Journal:  Skeletal Radiol       Date:  2011-05-01       Impact factor: 2.199

4.  Tumor-induced osteomalacia.

Authors:  Emily G Farrow; Kenneth E White
Journal:  Expert Rev Endocrinol Metab       Date:  2009-09-01

5.  Incidence of hypophosphatemia in advanced cancer patients: a recent report from a single institution.

Authors:  Taichi Yoshida; Daiki Taguchi; Koji Fukuda; Kazuhiro Shimazu; Masahiro Inoue; Katsunori Murata; Hiroyuki Shibata
Journal:  Int J Clin Oncol       Date:  2016-11-10       Impact factor: 3.402

6.  Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.

Authors:  Q L Huang; D S Feig; M E Blackstein
Journal:  J Endocrinol Invest       Date:  2000-04       Impact factor: 4.256

7.  Studies in a patient with tumor-induced hypophosphatemic osteomalacia.

Authors:  W G Ryan; S Gitelis; J R Charters
Journal:  Calcif Tissue Int       Date:  1986-06       Impact factor: 4.333

8.  Hypocalcemia due to avid calcium uptake by osteoblastic metastases of prostate cancer.

Authors:  M Szentirmai; C Constantinou; J M Rainey; J E Loewenstein
Journal:  West J Med       Date:  1995-12

Review 9.  Hypercalcaemia of malignancy.

Authors:  P J Kelly; J A Eisman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

10.  Systemic Control of Bone Homeostasis by FGF23 Signaling.

Authors:  Erica L Clinkenbeard; Kenneth E White
Journal:  Curr Mol Biol Rep       Date:  2016-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.